How Rare Diseases Were Affected By The COVID Pandemic
Source: THREAD
By Joyce Moore, Head of Rare Disease Solutions, THREAD
The latest issue of Raconteur (published as a supplement in The Times, UK) took a deep look at the rare disease landscape, including how rare diseases were affected by the COVID pandemic, and how patients who are engaged in the drug development process through clinical trials can build connections through digital platforms. It also highlighted how the increasing use of decentralized clinical trials (DCTs) is poised to improve both the patient experience and outcomes in the coming years.
To learn more about THREAD, visit their Clinical Leader page.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
THREAD
This website uses cookies to ensure you get the best experience on our website. Learn more